Similar effects were observed in our orthotopic mouse model of ovarian cancer, which demonstrated that simvastatin blocked tumor growth via inhibition of the MAPK and mTOR/S6 pathways and activation of the mitochondrial apoptosis pathway. This evidence concerns the gene MTOR and ovarian carcinoma.